Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that bolsters the drugmaker’s immunology pipeline.
Related Posts
Google Executive Picked to Supercharge News Efforts Has Resigned
Shailesh Prakash departs after two years at the tech giant. Relationships between Google News and publishers remain strained.
BHP’s Iron Ore, Copper Production Rises
Mining giant BHP Group said it produced more iron ore and copper over the past year thanks to new and acquired mines in Australia, but […]
Mitsubishi Corp. in Talks to Buy Stake in Exxon Mobil’s Texas Project
Mitsubishi Corp. is in talks to buy a stake in Exxon Mobil’s project in Baytown, Texas, which aims to be the world’s largest low-carbon ammonia […]